Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 7
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Ebrahimkhani, Mohammad R. Neiman, Jaclyn A. Shepard Raredon, Micha Sam B. Hughes, David J. and Griffith, Linda G. 2014. Bioreactor technologies to support liver function in vitro. Advanced Drug Delivery Reviews, Vol. 69-70, p. 132.


    Hajiasgharzadeh, Khalil Tavangar, Seyed Mohammad Javan, Mohammad Dehpour, Ahmad R. and Mani, Ali R. 2014. Does hepatic vagus nerve modulate the progression of biliary fibrosis in rats?. Autonomic Neuroscience, Vol. 185, p. 67.


    Bona, Silvia Filippin, Lidiane Isabel Di Naso, Fábio Cangeri de David, Cintia Valiatti, Bruna Isoppo Schaun, Maximiliano Xavier, Ricardo Machado and Marroni, Norma Possa 2012. Effect of Antioxidant Treatment on Fibrogenesis in Rats with Carbon Tetrachloride-Induced Cirrhosis. ISRN Gastroenterology, Vol. 2012, p. 1.


    Friedman, Scott L. 2011. Schiff's Diseases of the Liver.


    Friedman, Scott L. 2010. Evolving challenges in hepatic fibrosis. Nature Reviews Gastroenterology & Hepatology, Vol. 7, Issue. 8, p. 425.


    Mann, Jelena Chu, David C.K. Maxwell, Aidan Oakley, Fiona Zhu, Nian–Ling Tsukamoto, Hidekazu and Mann, Derek A. 2010. MeCP2 Controls an Epigenetic Pathway That Promotes Myofibroblast Transdifferentiation and Fibrosis. Gastroenterology, Vol. 138, Issue. 2, p. 705.


    Glaser, Shannon S. Gaudio, Eugenio Miller, Tim Alvaro, Domenico and Alpini, Gianfranco 2009. Cholangiocyte proliferation and liver fibrosis. Expert Reviews in Molecular Medicine, Vol. 11,


    ×
  • Expert Reviews in Molecular Medicine, Volume 10
  • 2008, e11

Wound healing and local neuroendocrine regulation in the injured liver

  • Mohammad R. Ebrahimkhani (a1), Ahmed M. Elsharkawy (a1) and Derek A. Mann (a1)
  • DOI: http://dx.doi.org/10.1017/S146239940800063X
  • Published online: 01 April 2008
Abstract

The hepatic wound-healing response is a complex process involving many different cell types and factors. It leads to the formation of excessive matrix and a fibrotic scar, which ultimately disrupts proper functioning of the liver and establishes cirrhosis. Activated hepatic myofibroblasts, which are derived from cells such as hepatic stellate cells (HSCs), play a key role in this process. Upon chronic liver injury, there is an upregulation in the local neuroendocrine system and it has recently been demonstrated that activated HSCs express specific receptors and respond to different components of this system. Neuroendocrine factors and their receptors participate in a complex network that modulates liver inflammation and wound healing, and controls the development and progression of liver fibrosis. The first part of this review provides an overview of the molecular mechanisms governing hepatic wound healing. In the second section, we explore important components of the hepatic neuroendocrine system and their recently highlighted roles in HSC biology and hepatic fibrogenesis. We discuss the therapeutic interventions that are being developed for use in antifibrotic therapy.

Copyright
Corresponding author
*Corresponding author: Prof. Derek A. Mann, Liver Group, Institute of Cellular Medicine, 4th Floor, Cookson Building, Medical School, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK. Tel: +44 191 2223851; Fax: +44 191 2225455; E-mail: derek.mann@ncl.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1V. Racanelli and B. Rehermann (2006) The liver as an immunological organ. Hepatology 43 (Suppl 1), S54-S62

2S.L. Friedman (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275, 2247-2250

3E. Novo (2007) Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells. Am J Pathol 170, 1942-1953

4G. Ramadori (1992) The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is down regulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun 183, 739-742

5J. Xu (2007) Characterization of a Putative Intrarenal Serotonergic System. Am J Physiol Renal Physiol 293, 1468-1475

6M. Bigliardi-Qi (2006) Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing. Differentiation 74, 174-185

7K. Kawamoto and H. Matsuda (2004) Nerve growth factor and wound healing. Prog Brain Res 146, 369-384

8T.A. Wynn (2007) Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117, 524-529

9A. Desmouliere , C. Chaponnier and G. Gabbiani (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 13, 7-12

10A. Meneghin and C.M. Hogaboam (2007) Infectious disease, the innate immune response, and fibrosis. J Clin Invest 117, 530-538

11N.S. Adzick (1985) Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 20, 315-319

12B.M. Stramer , R. Mori and P. Martin (2007) The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 127, 1009-1017

14J.P. Iredale (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117, 539-548

15L.J. McCawley and L.M. Martrisian (2001) Matrix metalloproteinases: they're not just for matrix anymore. Curr Opin Cell Biol 13, 534-540

16A.M. Elsharkawy , F. Oakley , D.A. Mann (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10, 927-939

17S.E. Mutsaers (1997) Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 29, 5-17

18G. Parsonage (2005) A stromal address code defined by fibroblasts. Trends Immunol 26, 150-156

19G.D. Sempowski (1995) Fibroblasts heterogeneity in the healing wound. Wound Repair Regen 3, 120-131

20S.J. Forbes (2004) A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126, 955-963

21F.P. Russo (2006) The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807-1821

22T. Kisseleva (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45, 429-438

23N. Kinnman and C. Housset (2002) Peribiliary myofibroblasts in biliary type liver fibrosis. Front Biosci 7, 496-503

24T. Knittel (1999) Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 117, 1205-1221

25M. Zeisberg (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282, 23337-23347

26R. Diaz (2008) Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 39, 102-115

27H. Robertson (2007) Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 45, 977-981

28A. Kaimori (2007) Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282, 22089-22101

30L. at al. Tang (1994) Phenotypic change in portal fibroblasts in biliary fibrosis. Liver 14, 76-82

31H. Chi and R.A. Flavell (2007) Immunology: sensing the enemy within. Nature 448, 423-424

32A. Canbay , S. Friedman and G.J. Gores (2004) Apoptosis: the nexus of liver injury and fibrosis. Hepatology 39, 273-278

33A. Watanabe (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology 46, 1509-1518

34J. J. Maher (1999) Leukocytes as modulators of stellate cell activation. Alcohol Clin Exp Res 23, 917-921

36P.C. Georges (2007) Increased Stiffness of the Rat Liver Precedes Matrix Deposition: Implications for Fibrosis. Am J Physiol Gastrointest Liver Physiol 293, 1147-1154

37Y.H. Paik (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37, 1043-1055

38A. Canbay (2004) The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 308, 1191-1196

39A. Canbay (2003) Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 83, 655-663

40E. Seki (2007) TLR4 enhances TGF-b signalling and hepatic fibrosis. Nat Med 13, 1324-1332

41F. Winau (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26, 117-129

43C. Liu (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278, 11721-11728

44D.H. Meyer , M.G. Bachem and A.M. Gressner (1990) Transformed fat storing cells inhibit the proliferation of cultured hepatocytes by secretion of transforming growth factor beta. J Hepatol 11, 86-91

45R. Bataller (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112, 1383-1394

46R. Bataller (2000) Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118, 1149-1156

47M. Pinzani (1995) Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology 21, 232-239

48H. Sprenger (1999) Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. J Hepatol 30, 88-94

49F. Marra (1999) Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29, 140-148

50V. Ankoma-Sey (1998) Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 17, 115-121

51N. Nieto (2006) Oxidative-stress and IL-6 mediate the fibrogenic effects of Kupffer cells on stellate cells. Hepatology 44, 1487-1501

52F.R. Murphy (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277, 11069-11076

53X. Zhou (2004) Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem 279, 23996-24006

54R.C. Benyon and M.J. Arthur (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 21, 373-384

55D. Alvaro (2007) Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 132, 415-431

59M. Marzioni (2005) Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 128, 121-137

60A. Mosca (2004) Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer. Dig Liver Dis (Suppl 1) 36, S60-S67

61M. Marzioni , G. Fava and A. Benedetti (2006) Nervous and neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis. World J Gastroenterol 12, 3471-3480

63P.A. di Sant'Agnese and A.T. Cockett (1996) Neuroendocrine differentiation in prostatic malignancy. Cancer 78, 357-361

64G.P. Amorino and S.J. Parsons (2004) Neuroendocrine cells in prostate cancer. Crit Rev Eukaryot Gene Expr 14, 287-300

65G.E. Walker (2006) Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 25, 1943-1954

66J.M. Nesland (1988) Neuroendocrine differentiation in breast lesions. Pathol Res Pract 183, 214-221

67F. Eren , C. Celikel and B. Güllüoğlu (2004) Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53. Pathol Oncol Res 10, 47-51

69S. DeMorrow (2007) Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts. J Biol Chem 282, 13098-13113

70K.T. Chang (2005) Role of IL-6 in neuroendocrine differentiation and chemosensitivity of non-small cell lung cancer. Am J Physiol Lung Cell Mol Physiol 289, L438-445

72W.W. Lin and M. Karin (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 117, 1175-1183

73A.M. Elsharkawy and D.A. Mann (2007) Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46, 590-597

74R.G. Ruddell (2006) A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 169, 861-876

75M.R. Ebrahimkhani (2006) Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut 55, 1606-1616

76Y.Y. Yang (2007) Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. Clin Sci (Lond) 112, 533-542

77A. Micera The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-beta. Clin Exp Allergy 35, 650-656

78L. Libbrecht and T. Roskams (2002) Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol 13, 389-396

80A. Geerts (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21, 311-335

81D. Cassiman (1999) Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol 155, 1831-1839

83D. Cassiman (2001) Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33, 148-158

85D. Alvaro , A. Gigliozzi and A.F. Attili (2000) Regulation and deregulation of cholangiocyte proliferation. J Hepatol 33, 333-340

86K.N. Lazaridis , M. Strazzabosco and N.F. LaRusso (2004) The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127, 1565-1577

88Y. Qiu (1998) Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3′-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A 95, 3644-3649

89A. Gigliozzi (2004) Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology 127, 1198-1209

90F. Oakley (2003) Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol 163, 1849-1858

91M.A. Passino (2007) Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 315, 1853–1856

92A. Micera (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98, 6162-6167

93A. Micera (2007) Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev 18, 245-256

94M.D. Gershon and J. Tack (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414

95M. Lesurtel (2006) Platelet-derived serotonin mediates liver regeneration. Science 312, 104-107

97A.R. Mani (2006) Endogenous opioids and liver disease. Scand J Gastroenterol 41, 1-11

98J.R. Thornton and M.S. Losowsky (1988) Opioid peptides and primary biliary cirrhosis. Br Med J 297, 1501-1504

100M.G. Swain (1992) Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. Gastroenterology 103, 630-635

101M. Marzioni (2007) Endogenous opioid peptides and chronic liver disease: from bedside to bench. J Hepatol 46, 583-586

102S. De Minicis (2008) Role Of Endogenous Opioids In Modulating HSC Activity In Vitro And Liver Fibrosis In Vivo. Gut 57, 352-364

103D. Centonze (2007) The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci 28, 180-187

104S.C. Woods (2008) Role of the endocannabinoid system in regulating cardiovascular and metabolic risk factors. Am J Med (Suppl 1) 120, S19-S25

105S.V. Siegmund (2005) Anandamide induces necrosis in primary hepatic stellate cells. Hepatology 41, 1085-1095

106B. Julien (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128, 742-755

107S.V. Siegmund (2007) The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 21, 2798-2806

108C. Hézode (2005) Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 42, 63-71

109F. Teixeira-Clerc (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 12, 671-676

110G. Kunos (2006) Cannabinoids hurt, heal in cirrhosis. Nat Med 12, 608-610

111M. Marzioni (2006) Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis. Gastroenterology 130, 1831-1847

112Y.H. Oo and J. Neuberger (2004) Options for treatment of primary biliary cirrhosis. Drugs 64, 2261-2271

113B.A. Johnson (2008) Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Biochem Pharmacol 75, 34-56

115Y. Iwakiri and R.J. Groszmann The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology (Suppl 1) 43, S121-S131

116M. Gary-Bobo (2007) Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. Hepatology 46, 122-129

117A. Nocito (2007) Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology 133, 608-618

S.L. Friedman and M.B. Bansal (2006) Reversal of hepatic fibrosis – fact or fantasy? Hepatology 43, S82-S88

J. Mann (2007) Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ 14, 275-285

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×